CASEY BOURQUE: Open Payments
NPI 1508482902 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,431 in 14 payments from 3 companies in 2025. Trend: 2023 $274 · 2024 $42 · 2025 $4,431
Consulting: $2,520Travel & lodging: $1,089Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $4,162 |
| REVANCE THERAPEUTICS, INC. | 4 | $244 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
Products named: DUPIXENT, DAXXIFY, VOQUEZNA.
Industry payments across AZ — which companies pay providers there.
